Inventor profile of:

Detlef Grawe

City:

Kleinromstedt

Country:

Germany

Published Applications:

12

Last publication date:

2016-09-22

Top Assignees for applications by Detlef Grawe

The entities that hold a legal rights for patent applications filed by inventor Grawe Detlef:

Recent patent applications by Grawe Detlef

Detlef Grawe from Kleinromstedt, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-09-22
US20160271145A1
Human necessities

METHOD FOR ENLARGING THE PARTICLE SIZE OF CRYSTALLINE MICROPARTICLES OF ACTIVE SUBSTANCE

#2 | 2013-06-27
US20130165421A1
Chemistry; metallurgy

4-[17BETA-METHOXY-17ALPHA-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11-BETA-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL)

#3 | 2013-02-14
US20130040141A1
Performing operations; transporting

Method for producing crystalline active ingredient particles

#4 | 2011-10-20
US20110257142A1
Chemistry; metallurgy

Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil)

#5 | 2011-06-16
US20110144071A1
Human necessities

Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs

#6 | 2011-03-17
US20110065952A1
Performing operations; transporting

Arrangement and method for producing high-purity crystals

#7 | 2010-09-21
US10296463
-

Solid body forms of mesoprogestin 11β-{4E-(hydroxyiminomethyl)-phenyl}-17α methoxymethyl-17β-methoxy-estra-4,9-dien-3-one

#8 | 2009-02-26
US20090054387A1
Chemistry; metallurgy

Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil)

#9 | 2007-03-20
US10417559
-

Process for production of crystals of 11μ-benzaldoxim-estra-4,9-diene derivatives, crystals obtained thereby and pharmaceutical preparations containing them

#10 | 2006-12-12
US10417557
-

Process for production of steroid crystals, steroid crystals obtained thereby and pharmaceutical preparations containing them

#11 | 2005-12-13
US10381535
-

Method for isolating pharmaceutically exploitable etidronate disodium

#12 | 2005-06-07
US9913112
-

Laminates containing an active substance transdermal system

InventorID:

89802 ⎘